IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,742,142 | -8.8% | 284,750 | +0.8% | 0.03% | -3.4% |
| Q2 2023 | $3,007,077 | -84.8% | 282,620 | -85.0% | 0.03% | -85.4% |
| Q1 2023 | $19,843,318 | -4.4% | 1,886,247 | +12.6% | 0.20% | -8.7% |
| Q4 2022 | $20,759,309 | +19.4% | 1,675,489 | -0.2% | 0.22% | +10.7% |
| Q3 2022 | $17,386,000 | +1.0% | 1,678,211 | +12.4% | 0.20% | +11.3% |
| Q2 2022 | $17,222,000 | +17.9% | 1,493,637 | +28.7% | 0.18% | +42.7% |
| Q1 2022 | $14,603,000 | +160.4% | 1,160,846 | +141.4% | 0.12% | +195.2% |
| Q4 2021 | $5,607,000 | +23262.5% | 480,849 | +20555.0% | 0.04% | – |
| Q2 2020 | $24,000 | +26.3% | 2,328 | +24.8% | 0.00% | – |
| Q1 2020 | $19,000 | – | 1,865 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
| 13D Management LLC | 600,431 | $6,923,000 | 3.06% |
| BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
| Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
| Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
| Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
| ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
| Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
| CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |